文档库 最新最全的文档下载
当前位置:文档库 › 创伤患者深静脉血栓预防的监测与个体化治疗

创伤患者深静脉血栓预防的监测与个体化治疗

创伤患者深静脉血栓预防的监测与个体化治疗

作者:杨军, 王毅

作者单位:300211,天津医院检验科

刊名:

中华创伤杂志

英文刊名:Chinese Journal of Trauma

年,卷(期):2012,28(11)

参考文献(32条)

1.陈建英;任文秀人工髋关节置换术后深静脉血栓形成的护理体会[期刊论文]-中外医疗 2011(02)

2.杨扬;王玉甫;齐宝庆低分子肝素预防创伤后下肢深静脉血栓的临床研究[期刊论文]-天津医科大学学报 2007(02)

3.吴显培;赵国平;秦汉兴低分子肝素预防人工全髋全膝关节置换术后深静脉血栓形成[期刊论文]-现代医院 2010(03)

4.邱贵兴;杨庆铭;余楠生低分子肝素预防髋、膝关节手术后下肢深静脉血栓形成的多中心研究[期刊论文]-中华骨科杂志 2006(12)

5.Caprini JA;Arcelus J;Sehgal LR The use of low molecular weight heparins for the prevention of postoperative venous thromboembolism in general surgery.A survey of practice in the United States[外文期刊] 2002(01)

6.Timothy AM;Selene C;Gehan D No difference in risk for thrombocytopenia during treatment of pulmonary embolism and deep venous thrombosis with either low molecular weight heparin or unfractionated heparin[外文期刊] 2007(04)

7.Camporese G;Bemardi E;Prandoni P Low-molecular-weight heparin versus compression stockings for thrombopro-phylaxis after knee arthroscopy:a randomized trial[外文期刊] 2008(02)

8.Friedman R J;Gallus AS;Cushner FD Physician compliance with guidelines for deep-vein thrombosis prevention in total hip and knee arthroplasty[外文期刊] 2008(01)

9.Otero-Femández R;Gómez-Outes A;Martínez-González J Evaluation of the effectiveness and safety of bemiparin in a large population of orthopedic patients in a normal clinical practice[外文期刊] 2008(01)

10.Ugaki H;Enomoto T;Fujiwara K Safety and efficacy of lower dose unfractionated heparin for prophylaxis of deep vein thrombosis and pulmonary embolism in asian population 2008(06)

11.谢忠海低分子肝素钙预防高龄患者下肢深静脉血栓[期刊论文]-中国现代医生 2010(35)

12.王强;盛伟斌;姜曙祥老年髋关节周围骨折围手术期应用低分子肝素预防下肢深静脉血栓的研究[期刊论文]-中国骨与关节损伤杂志 2010(02)

https://www.wendangku.net/doc/311087888.html,ssen MR;Gallus A;Raskob GE Apixaban versus enoxapariu for thromboprophylaxis after hip replacement 2010(26)

14.Green L;Lawrie AS;Patel S The impact of elective knee/hip replacement surgery and thromboprophylaxis with rivaroxaban or dalteparin on thrombin generation 2010(05)

15.郑花鸯;严安;熊慧肿瘤的个体化医疗[期刊论文]-肿瘤 2009(09)

16.史旭波;胡大一低分子肝素治疗实验室监测现状[期刊论文]-心血管病学进展 2007(04)

17.A1Dieri R;Wagenvoord R;van Dedem GW The inhibition of blood coagulation by heparins of different molecular weight is caused by a common functional motif-the C-domain 2003(05)

18.Hemker HC;A1Dieri R;Wagenvoord R The Choay domain-the structure responsible for the anticoagulant action of heparins 2003(01)

19.British Committee for Standards in Haematology Guidelines on the use and monitoring of heparin 2006(01)

20.CaoYB;Zhang JD;Shen H Rivaroxaban versus enoxaparin for thromboprophylaxis after total hip or knee arthroplasty:a meta-analysis of randomized controlled trials 2010(11)

21.Salazar CA;Malaga G;Malasquez G Direct thrombin inhibitors versus vitamin K antagonists or low molecular weight heparins for prevention of venous thromboembolism following total hip or knee replacement 2010(04)

22.Walsh M;Preston C;Bong M Relative risk factors for requirement of blood transfusion after total hip arthroplasty 2007(08)

23.The Columbus Investigators Low-molecular-weight heparin in the treatment of patients with venous thromboembolism

24.Hemker HC;Al Dieri R;Béguin S Laboratory monitoring of low molecular weight heparin therapy part Ⅱ.Monitoring LMWH therapy?For the moment a non-question 2005(03)

25.Camporese G;Bernardi E;Prandoni P Low molecular weight heparin versus compression stockings for thromboprophy-laxis after knee arthroscopy:a randomized trial[外文期刊] 2008(02)

26.Angkasuwapala K;Ratanasumawong K;Ngarmukos T Effect of unfractionated heparin and low molecular weight heparin on hospital mortality in patients with non ST elevation acute coronary syndrome(ACS) 2007(Suppl 1)

27.Van PY;Cho SD;Underwood SJ Thrombelastography versus AntiFactor Xa levels in the assessment of prophylactic-dose enoxaparin in critically ill patients 2009(06)

28.Mahe I;Gouin-Thibault I;Drotiet L Elderly medical patients treated with prophylactic dosages of

enoxaparin:influence of renal function on anti Xa activity level 2007(01)

29.Cavusoglu E;Lakhani M;Marmur JD The activated clotting time(ACT)can be used to monitor enoxaparin and dalteparin after intravenous administration 2005(08)

30.牛新乐;严宗毅;刘剑刚血栓弹力图的新数学模型及其应用[期刊论文]-生物物理学报 2000(02)

31.蔡海英;叶立刚;徐善祥血栓弹力图在严重多发伤患者中的初步应用[期刊论文]-中华创伤杂志 2011(12)

32.Coppell JA;Thalheimer U;Zambruni A The effects of unffactionated heparin,low molecular weight heparin and danaparoid on the thromboelastogram(TEG):an in-vitro comparison of standard and heparinase-modified TEGs with conventional coagulation assays 2006(02)

本文链接:https://www.wendangku.net/doc/311087888.html,/Periodical_zhcs201211025.aspx

相关文档
相关文档 最新文档